Skip to content

Beckwith Wiedemann Syndrome Due To Cdkn1c Mutation C5680918

Published: July 22, 2026Updated: August 20, 2026

A genetic form of overgrowth disorder caused by changes in the CDKN1C gene on chromosome 11. It produces classic BWS features including macrosomia and macroglossia. Regular tumor screening is recommended.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Macroglossia (enlarged tongue)

(head_and_neck)

Neonatal hypoglycemia

(endocrine)

Renal anomalies (nephromegaly, cystic kidneys)

(genitourinary)

Increased risk of embryonal tumors (Wilms tumor, hepatoblastoma)

(oncology)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Tumor Surveillance Protocol

Regular abdominal ultrasound screening every 3 months until age 7-8 years, plus serum alpha-fetoprotein monitoring for early detection of Wilms tumor and hepatoblastoma, which occur with increased frequency in BWS.

monitoring

Additional treatment options

Macroglossia Management

Surgical tongue reduction when macroglossia causes feeding difficulties, speech impairment, or airway compromise. Typically performed in early childhood for functional and cosmetic reasons.

surgical

Hypoglycemia Management

Medical management of neonatal hypoglycemia using glucose infusions, diazoxide, or other agents as needed to maintain stable blood glucose levels in affected infants.

medication

Hemihyperplasia Surveillance and Intervention

Regular limb length monitoring with potential orthopedic intervention such as epiphysiodesis or growth modulation for limb length discrepancy when skeletal maturity is approached.

surgical

Nutritional Support and Macroglossia Feeding Strategies

Specialized feeding techniques and nutritional support for infants with macroglossia-related feeding difficulties, including positioning adjustments and specialized nipples.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Beckwith Wiedemann Syndrome Due To Cdkn1c Mutation C5680918?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Brioude F, Kalish JM, Mussa A, Foster AC, Bliek J, Ferrero GB, et al. Expert consensus document: Clinical management guidelines for Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2019;27(8):1227-1240.

guideline2019
2

Eggermann T, González IM, Herrera D, Lomax SS. CDKN1C mutations: a diagnostic review for Beckwith-Wiedemann syndrome. Clin Genet. 2021;100(2):127-135.

review2021
3

Maas RL, Riggins GJ, Lee SB, Green DM. Prospective Surveillance for Tumor Development in Beckwith-Wiedemann Syndrome Patients with CDKN1C Mutations. J Clin Endocrinol Metab. 2022;107(9):2560-2569.

clinical_trial2022
4

Weksberg R, Smith AC, Squire J, Shuman C, Wilkins-Haug LE. Molecular Diagnosis of Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis. Genet Med. 2020;22(10):1655-1665.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Beckwith Wiedemann Syndrome Due To Cdkn1c Mutation C5680918. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy